Early-stage breast cancer patients are typically treated through surgical resection of the primary tumor, radiation therapy, and combinations of oral or systemic drug therapies based on the specific characteristics of the breast cancer (i.e., HER2+, ER/PR+, triple negative for the mentioned receptors/markers, etc.)[1]. This evidence concerns the gene ERBB2 and breast carcinoma.